Detalhe da pesquisa
1.
Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.
Ann Oncol
; 32(6): 810-811, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33662499
2.
Frequent intragenic rearrangements of DPYD in colorectal tumours.
Pharmacogenomics J
; 15(3): 211-8, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25348620
3.
Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study.
Br J Cancer
; 110(11): 2728-37, 2014 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-24800948
4.
Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study.
Chemotherapy
; 58(5): 371-80, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-23235319
5.
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.
Ann Oncol
; 21(9): 1765-1771, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20233745
6.
Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model.
Ann Oncol
; 20(10): 1703-7, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19542251
7.
Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model.
Br J Cancer
; 99(1): 93-9, 2008 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-18577994
8.
Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer.
Ann Oncol
; 19(12): 2033-8, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18632722
9.
Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.
Oral Oncol
; 67: 70-76, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28351583
10.
Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft.
Eur J Cancer
; 41(10): 1467-73, 2005 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15919200
11.
Pharmacokinetics of sunitinib in hemodialysis.
Ann Oncol
; 20(1): 190-2, 2009 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18801884
12.
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients.
Clin Pharmacol Ther
; 83(3): 413-5, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-17637782
13.
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer.
J Cancer Res Clin Oncol
; 134(1): 51-7, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17593391
14.
PK/PD model of indisulam and capecitabine: interaction causes excessive myelosuppression.
Clin Pharmacol Ther
; 83(6): 829-39, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17851564
15.
EGFR in colorectal cancer: more than a simple receptor.
Ann Oncol
; 17(6): 962-7, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16524971
16.
Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients.
Ann Oncol
; 16(6): 934-41, 2005 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15829495
17.
Pharmacological background of EGFR targeting.
Ann Oncol
; 15(7): 1007-12, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15205192
18.
EGFR expression in colon cancer: a break in the clouds.
Ann Oncol
; 17(12): 1850-1, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-16766589
19.
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patients.
Ann Oncol
; 14(8): 1329-30, 2003 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12881401